Abbott Laboratories (ABT) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-01-28 (expected, before the open). EPS estimate 1.64, revenue estimate 13.21B.
Over the last 12 reports the stock moved 4.8% on average (either way), rising 5 times and falling 7. EPS beat estimates 6 of 12 times; revenue 8 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-21 | 1.42 | 1.42 | +0.0% | 13.01B | 12.99B | +0.1% |
| Q2 FY2026 | 2026-07-16 | 1.31 | 1.28 | +2.3% | 12.59B | 12.52B | +12.8% |
| Q1 FY2026 | 2026-04-16 | 1.15 | 1.14 | +0.9% | 11.16B | 11.00B | -4.7% |
| Q4 FY2025 | 2026-01-22 | 1.50 | 1.50 | +0.0% | 11.46B | 11.80B | -11.0% |
| Q3 FY2025 | 2025-10-15 | 1.30 | 1.30 | +0.0% | 11.37B | 11.39B | -4.2% |
| Q2 FY2025 | 2025-07-17 | 1.26 | 1.26 | +0.0% | 11.14B | 11.09B | -6.1% |
| Q1 FY2025 | 2025-04-16 | 1.09 | 1.07 | +1.9% | 10.36B | 10.41B | +3.8% |
| Q4 FY2024 | 2025-01-22 | 1.34 | 1.34 | +0.0% | 10.97B | 11.03B | +5.5% |